HYPERTRIGLYCERIDEMIC ACUTE PANCREATITIS: PROGRESS AND PROBLEMS
Abstract
The purpose of the review. Analyze basic data on the hypertrigliceridemia (HTG) role in the pathogenesis of HTG-associated acute pancreatitis (AP), and the current treatment of the disease. Recent literature data. HTG-associated AP met in 5-15 % of the AP cases. In the HTG-associated AP pathogenesis leading role belongs to obstruction of capillaries by TG and chylomicrons, local ischemia of the pancreas, as well as the accumulation of toxic free fatty acids by TG hydrolysis, resulting in damage to the acinary cells and capillary epithelium, which exacerbates acidosis and stimulates premature trypsinogen activation with the initiation of acute edematous or necrotizing pancreatitis. Modern treatment of HTG-associated AP include plasmapheresis to the TG levels of 300-500 mg/dL, then - diet, refuse from alcohol, drugs: omega-3 fatty acids, fibrates, nicotinic acid. Planned for lipoprotein lipase deficiency gene therapy by injecting a viral vector alipogen tiparvovek, resulting in significantly increasing of lipoprotein lipase activity, decreased plasma triglycerides and chylomicrons levels and decreases the incidence of AP.
About the Author
I. N. Grigorieva
Institute of Internal Medicine and Preventive Medicine; National Research Novosibirsk State University
Russian Federation
Russian Federation
References
1. Zhang X.L., Li F., Zhen Y.M., Li A., Fang Y. Clinical study of 224 patients with hypertriglyceridemia pancreatitis // Chin. Med. J. (Engl). 2015. Vol. 128, N 15. P. 2045-2049.
2. Stefanutti C., Labbadia G., Morozzi C. Severe hypertriglyceridemia-related acute pancreatitis // Ther. Apher. Dial. 2013. Vol. 17, N 2. P. 130-137.
3. Yuan G., Al-Shali K.Z., Hegele R.A. Hypertriglyceridemia: its etiology, effects and treatment // CMAJ. 2007. Vol. 176, N 8. P. 1113-1120.
4. Smelt A.H. Triglycerides and gallstone formation // Clin. Chim. Acta. 2010. Vol. 411, N 21-22. P. 1625-1631.
5. Chang M.C., Su C.H., Sun M.S. et al. Etiology of acute pancreatitis-a multi-center study in Taiwan // Hepatogastroenterology. 2003. Vol. 50. P. 1655-1657.
6. Toskes P.P. Hyperlipidemic pancreatitis // Gastroenterol. Clin. North Am. 1990. Vol. 19. P. 783-791.
7. Scherer J., Singh V., Pitchumoni C.S., Yadav D. Issues in Hyperlipidemic Pancreatitis - An Update // J. Clin. Gastroenterol. 2014. Vol. 48, N 3. P. 195-203.
8. Bhavsar B., Bhatt А. Steroid Induced Hyperlipidemic Pancreatitis and New Onset Diabetes Mellitus. Treatment with Plasmapheresis // JOP. J. Pancreas (Online). 2008. Vol. 9, N 5. P. 664-665.
9. Ivanova R., Puerta S., Garrido A. et al. Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis // Hepatobiliary Pancreat. Dis. Int. 2012. Vol. 11, N 1. P. 96-101.
10. Carr R., Rejowski B., Cote G., Pitt H., Zyromski N. Systematic review of hypertriglyceridemia-induced acute pancreatitis: A more virulent etiology? // Pancreatology. 2016. Vol. 16, N 4. P. 469-476.
11. Valdivielso P., Ramírez-Bueno A., Ewald N. Current knowledge of hypertriglyceridemic pancreatitis // Eur. J. Intern. Med. 2014. Vol. 25, N 8. P. 689-694.
12. Lindkvist B., Appelros S., Regnér S., Manjer J. A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose // Pancreatology. 2012. Vol. 12, N 4. P. 317-324.
13. Bessembinders K., Wielders J., van de Wiel. A Severe hypertriglyceridemia influenced by alcohol (SHIBA) // Alcohol. Alcohol. 2011. Vol. 46, N 2. P. 113-116.
14. Subramanian S., Chait A. Hypertriglyceridemia secondary to obesity and diabetes // Biochim. Biophys. Acta. 2012. Vol. 1821, N 5. P. 819-825.
15. Fortson M.R., Freedman S.N., Webster P.D.3. Clinical assessment of hyperlipidemic pancreatitis // Am. J. Gastroenterol. 1995. Vol. 90. P. 2134-2139.
16. Mali P. Pancreatitis in pregnancy: etiology, diagnosis, treatment, and outcomes // Hepatobiliary Pancreat. Dis. Int. 2016. Vol. 15, N 4. P. 434-438.
17. Huang C., Liu J., Lu Y., Fan J. Clinical features and treatment of hypertriglyceridemia-induced acute pancreatitis during pregnancy: A retrospective study // J. Clin. Apher. 2016. Mar 4. [Epub ahead of print]
18. Berglund L., Brunzell J.D., Goldberg A.C., Goldberg I.J., Sacks F., Murad M.H., Stalenhoef A.F. Endocrine society. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline // J. Clin. Endocrinol. Metab. 2012. Vol. 97, N 9. P. 2969-2989.
19. Pedragosa A., Merino J., Aranda J.L., Galiana J., Godoy D. en nombre del Registro de HTG de la SEA. Clinical profile of patients with very high hypertriglyceridemia from the Registry of Hypertriglyceridemia of the Spanish Atherosclerosis Society // Clin. Investig. Arterioscler. 2013. Vol. 25, N 1. P. 8-15.
20. Klop B., Wouter Jukema J., Rabelink T.J., Cabezas M.C. A physician’s guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy // Panminerva Med. 2012. Vol. 54, N 2. P. 91-103.
21. Григорьева И.Н., Ефимова О.В., Суворова Т.С., Тов Н.Л. Панкреатит, рак поджелудочной железы и ожирение: гипотезы и факты // ЭиКГ. 2014. № 9. С. 4-10.
22. Hodis H.N., Mack W.J., Krauss R. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects // Clin. Cardiol. 1999. Vol. 22, N II. P. 15-20.
23. Grigorieva I.N., Nikitenko T.M., Romanova T.I., Ragino Y., Maximov V., Voevoda M. Polymorphism of IL-1beta and TNF-alpha Genes and Serum Levels in Patients with Cronic (CP) and Acute Pancreatitis (AP) // Pancreatology. 2010. Vol. 10. P. 315-316.
24. Klop B., Rego A.T., Cabezas M.C. Alcohol and plasma triglycerides // Curr. Opin. Lipidol. 2013. Vol. 24, N 4. P. 321-326.
25. Van de Wiel A. The effect of alcohol on postprandial and fasting triglycerides // Int. J. Vasc. Med. 2012. Vol. 2012. P. 862504.
26. Григорьева И.Н. Алкогольный панкреатит // Consilium Medicum. 2011. N 1. P. 51-55.
27. Григорьева И.Н., Никитенко Т.М., Брагина О.М., Романова Т.И., Симонова Г.И., Ямлиханова А.Ю., Веревкин Е.Г. Особенности питания у больных с хроническим и острым панкреатитом // РЖГГК. 2009. № 5. C. 139.
28. Григорьева И.Н. Острый и хронический панкреатит. Новосибирск: Наука, 2010. 101 с.
29. Григорьева И.Н., Логвиненко Е.В., Ямлиханова А.Ю. Проблема ожирения при остром и хроническом панкреатите в сочетании с желчнокаменнойболезнью // ЭиКГ. 2012. № 7. С. 64-67.
30. Григорьева И.Н., Никитенко Т.М., Ямлиханова А.Ю., Романова Т.И., Максимов В.Н., Воевода М.И. Алкогольный панкреатит: гендерные, возрастные и генетические аспекты // Бюлл. СО РАМН. 2009. № 3. P. 42-47.
31. Weiss F.U., Simon P., Mayerle J. et al. Germline mutations and gene polymorphism associated with human pancreatitis // Endocrinol. Metab. Clin. North Am. 2006. Vol. 35. P. 289-302viii-ix.
32. Lindberg D.A. Acute pancreatitis and hypertriglyceridemia // Gastroenterol. Nurs. 2009. Vol. 32, N 2. P. 75-82; quiz 83-84.
33. Coca-Prieto I., Valdivielso P., Olivecrona G. et al. Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis // BMC. Gastroenterol. 2009. Vol. 9. P. 46.
34. Fong L.G., Young S.G., Beigneux A.P., Bensadoun A., Oberer M., Jiang H., Ploug M. GPIHBP1 and Plasma Triglyceride Metabolism // Trends Endocrinol. Metab. 2016. Vol. 27, N 7. P. 455-469.
35. Ariza M.J., Martínez-Hernández P.L., Ibarretxe D., Rabacchi C. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis // J. Clin. Lipidol. 2016. Vol. 10, N 1. P. 92-100.e1.
36. Григорьева И.Н., Никитенко Т.М., Тихонов А.В., Романова Т.И., Максимов В.Н., Шахтшнейдер Е.В., Малютина С.К., Воевода М.И. Генетические аспекты заболеваний органов пищеварения. Ч. I // Терапевт. арх. 2010. № 2. С. 62-66.
37. Chang Y.T., Chang M.C., Su T.C., Liang P.C. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis // Clin. Chem. 2008. Vol. 54, N 1. P. 131-138.
38. Navina S., Acharya C., DeLany J.P., Yadav D., Singh V.P. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity // Sci. Transl. Med. 2011. Vol. 3, N 107. P. 107-110.
39. Tsuang W., Navaneethan U., Ruiz L. et al. Hypertriglyceridemic pancreatitis: presentation and management // Am. J. Gastroenterol. 2009. Vol. 104, N 4. P. 984-991.
40. Navarro S., Cubiella J., Feu F. et al. Hypertriglyceridemic acute pancreatitis. Is its clinical course different from lithiasic acute pancreatitis? // Med. Clin. (Barc). 2004. Vol. 123, N 15. P. 567-570.
41. Григорьева И.Н., Романова Т.И., Никитенко Т.М., Ямлиханова А.Ю. Характеристика болевого и диспептического синдромов у больных билиарным и алкогольным ОП и ХП // РЖГГК. 2011. № 1 (Прил. 37). С. 176.
42. Melnick S., Nazir S., Gish D., Aryal M.R. Hypertriglyceridemic pancreatitis associated with confounding laboratory abnormalities // J. Commun. Hosp. Intern. Med. Perspect. 2016. Vol. 6, N 3. P. 31808.
43. Jiang C.Y., Han T.Q., Feng F.L. et al. Clinical characteristics of acute pancreatitis patients with elevated serum triglyceride concentration // Chin. J. Dig. Dis. 2005. Vol. 6, N 1. P. 43-46.
44. Tariq H., Gaduputi V., Peralta R., Abbas N., Nayudu S.K., Thet P., Zaw T. Serum Triglyceride Level: A Predictor of Complications and Outcomes in Acute Pancreatitis? // Can. J. Gastroenterol. Hepatol. 2016. Vol. 2016. P. 8198047.
45. Vipperla K., Somerville C., Furlan A., Koutrompakis E., Rabinovitz M., Whitcomb D.C., Yadav D. Clinical Profile and Natural Course in a Large Cohort of Patients With Hypertriglyceridemia and Pancreatitis // J. Clin. Gastroenterol. 2016. Jun 17. [Epub ahead of print].
46. Linares L., Pelletier A., Czernichow S. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia // Pancreas. 2008. Vol. 37, N 1. P. 13-22.
47. Cheng L., Luo Z., Xiang K., Ren J., Huang Z., Tang L., Tian F. Clinical significance of serum triglyceride elevation at early stage of acute biliary pancreatitis // BMC. Gastroenterol. 2015. Vol. 15. P. 19.
48. Gavva C., Sarode R., Agrawal D., Burner J. Therapeutic plasma exchange for hypertriglyceridemia induced pancreatitis: A rapid and practical approach // Transfus. Apher. Sci. 2016. Vol. 54, N 1. P. 99-102.
49. Ewald N., Kloer H.U. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis // Clin. Res. Cardiol. Suppl. 2012. Vol. 7 (Suppl 1). P. 31-35.
50. Kyriakidis A.V., Raitsiou B., Sakagianni A. et al. Management of acute severe hyperlipidemic pancreatitis // Digestion. 2006. Vol. 73. P. 259-264.
51. Szczepiorkowski Z.M., Winters J.L., Bandarenko N., Kim H.C., Linenberger M.L., Marques M.B. Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis // J. Clin. Apher. 2010. Vol. 25, N 3. P. 83-177.
52. Afari M.E., Shafqat H., Shafi M., Marmoush F.Y., Roberts M.B., Minami T. Hypertriglyceridemia-Induced Pancreatitis: A Decade of Experience in a Community-Based Teaching Hospital // R. I. Med. J. (2013). 2015. Vol. 98, N 12. P. 40-43.
53. He W., Lu N. Emergent triglyceride-lowering therapy for hypertriglyceridemic pancreatitis // Hepatogastroenterology. 2015. Vol. 62, N 138. P. 429-434.
54. Maki K.C., Bays H.E., Dicklin M.R. Treatment options for the management of hypertrigly-ceridemia: strategies based on the best-available evidence // J. Clin. Lipidol. 2012. Vol. 6, N 5. P. 413-426.
55. Gaudet D., Méthot J., Déry S., Brisson D., Essiembre C., Tremblay G., Tremblay K., de Wal J., Twisk J., van den Bulk N., Sier-Ferreira V., van Deventer S. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial // Gene Ther. 2013. Vol. 20, N 4. P. 361-369.
56. Haddley K. Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency // Drugs Today (Barc). 2013. Vol. 49, N 3. P. 161-170.
57. Wierzbicki A.S., Viljoen A. Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency // Expert Opin. Biol. Ther. 2013. Vol. 13, N 1. P. 7-10.
58. Rashid N., Sharma P.P., Scott R.D., Lin K.J., Toth P.P. All-Cause and Acute Pancreatitis Health Care Costs in Patients With Severe Hypertriglyceridemia // Pancreas. 2016. Aug 11. [Epub ahead of print].
Review
For citations:
Grigorieva I.N. HYPERTRIGLYCERIDEMIC ACUTE PANCREATITIS: PROGRESS AND PROBLEMS. Ateroscleroz. 2017;13(1):41-48. (In Russ.)
Views:
1055
Email this article 